|
|
 |
|
Total Number of Holdings (excluding cash): 50
| Exact Sciences Corporation |
EXAS |
30063P105 |
684 |
$69,220.80 |
3.26% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
705 |
$63,301.95 |
2.98% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
93 |
$52,765.41 |
2.48% |
| Waters Corporation |
WAT |
941848103 |
120 |
$47,734.80 |
2.25% |
| Align Technology, Inc. |
ALGN |
016255101 |
317 |
$46,510.24 |
2.19% |
| Revvity, Inc. |
RVTY |
714046109 |
452 |
$46,298.36 |
2.18% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
539 |
$45,960.53 |
2.16% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
31 |
$45,510.79 |
2.14% |
| The Cooper Companies, Inc. |
COO |
216648501 |
583 |
$45,130.03 |
2.12% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
562 |
$44,532.88 |
2.10% |
| Penumbra, Inc. |
PEN |
70975L107 |
153 |
$44,623.98 |
2.10% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
184 |
$44,453.43 |
2.09% |
| Steris Plc |
STE |
G8473T100 |
169 |
$44,428.41 |
2.09% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
76 |
$44,471.40 |
2.09% |
| Danaher Corporation |
DHR |
235851102 |
197 |
$44,155.58 |
2.08% |
| Hologic, Inc. |
HOLX |
436440101 |
589 |
$44,080.76 |
2.07% |
| Agilent Technologies, Inc. |
A |
00846U101 |
292 |
$43,829.20 |
2.06% |
| Alcon Inc. |
ALC.SW |
H01301128 |
552 |
$43,712.85 |
2.06% |
| Hoya Corporation |
7741.JP |
J22848105 |
294 |
$43,632.34 |
2.05% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
505 |
$43,626.95 |
2.05% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
134 |
$43,081.00 |
2.03% |
| Medtronic Plc |
MDT |
G5960L103 |
418 |
$43,196.12 |
2.03% |
| Olympus Corporation |
7733.JP |
J61240107 |
3,240 |
$43,040.63 |
2.03% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
369 |
$42,635.10 |
2.01% |
| Boston Scientific Corporation |
BSX |
101137107 |
418 |
$42,222.18 |
1.99% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
455 |
$41,674.23 |
1.96% |
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
152 |
$41,669.28 |
1.96% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
1,452 |
$41,249.24 |
1.94% |
| Becton, Dickinson and Company |
BDX |
075887109 |
214 |
$41,049.48 |
1.93% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
1,917 |
$41,096.78 |
1.93% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
805 |
$40,485.53 |
1.91% |
| Stryker Corporation |
SYK |
863667101 |
109 |
$40,582.88 |
1.91% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
421 |
$39,893.96 |
1.88% |
| Masimo Corporation |
MASI |
574795100 |
276 |
$39,749.52 |
1.87% |
| Insulet Corporation |
PODD |
45784P101 |
127 |
$39,475.41 |
1.86% |
| DexCom, Inc. |
DXCM |
252131107 |
612 |
$38,874.24 |
1.83% |
| Cochlear Limited |
COH.AU |
Q25953102 |
215 |
$38,720.46 |
1.82% |
| Abbott Laboratories |
ABT |
002824100 |
301 |
$38,531.01 |
1.81% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,129 |
$38,435.41 |
1.81% |
| Teleflex Incorporated |
TFX |
879369106 |
334 |
$38,212.94 |
1.80% |
| BioMerieux |
BIM.FP |
F1149Y232 |
300 |
$37,789.08 |
1.78% |
| Terumo Corporation |
4543.JP |
J83173104 |
2,460 |
$37,830.09 |
1.78% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
2,263 |
$37,198.36 |
1.75% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
147 |
$37,147.22 |
1.75% |
| ResMed Inc. |
RMD |
761152107 |
147 |
$36,511.86 |
1.72% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
2,785 |
$36,545.25 |
1.72% |
| Amplifon SpA |
AMP.IM |
T0388E118 |
2,331 |
$36,073.46 |
1.70% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
729 |
$36,045.45 |
1.70% |
| Baxter International Inc. |
BAX |
071813109 |
1,817 |
$34,668.36 |
1.63% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
3,234 |
$30,062.25 |
1.41% |
| US Dollar |
$USD |
|
2,504 |
$2,504.31 |
0.12% |
| Japanese Yen |
$JPY |
|
64,646 |
$415.76 |
0.02% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.15 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|